Centennial, Colo. — October 24, 2017 — AlloSource, one of the nation’s largest providers of cellular, cartilage, bone, skin and soft-tissue allografts to advance patient healing in surgical procedures, will highlight AlloFuse® Select CM at the North American Spine Society Annual Meeting (NASS).

AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to support the initiation and nurturing of bone growth, leading to consistent spinal fusion outcomes and delivering the benefits of autograft bone without the potential drawbacks. The product engages the body’s natural healing power and can be used in a variety of spinal, neurologic, and orthopedic procedures.

“AlloFuse Select CM represents our ongoing dedication to delivering advanced allograft solutions that help restore mobility for recipients,” said Kerr Holbrook, AlloSource Chief Commercial Officer. “We are proud to support spine surgeons by expanding our biologics portfolio to provide a range of products that assist in patient healing.”

This cellular allograft matrix is moldable and compressible for insertion into interbody implants or placement around anatomical structures. AlloFuse Select CM enhances AlloSource’s current orthobiologic portfolio, which includes AlloStem® Cellular Bone Allograft, AlloFuse® Cortical Fibers and AlloFuse Fiber Boat, AlloFlex® Plus and AlloFuse putty, paste and gel allografts.

Surgeon experts Dr. Shay Bess and Dr. Peter Passias will be at AlloSource’s NASS booth #1033 for peer-topeer discussion during NASS, which is taking place October 25-28, 2017 in Orlando, Florida.